RAP-103

DB28444ExperimentalProtein Based Therapies

RAP-103 is a multi-chemokine receptor antagonist which is orally active.

Code names
RAP-103

Resolves to

Targets
P41597CCR2P51681CCR5P51685CCR8

What you can answer from here — as of July 08, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with RAP-103, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In